Oumayma Mnafe: ThroLy and IMPEDE VTE Scores in Hematologic Malignancies
Oumayma Mnafe, Clinical Hematology Resident at Faculty of Medicine, Pharmacy and Dental Medicine of Fez, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Cureus Journal of Medical Science, adding:
“Pleased to share our latest publication about Clinical Profile of Venous Thromboembolism and Applicability of the ThroLy and IMPEDE VTE Risk Scores in Patients With Lymphoma and Multiple Myeloma.
A Moroccan Single-Center Retrospective Study.”
Title: Clinical Profile of Venous Thromboembolism and Applicability of the ThroLy and IMPEDE VTE Risk Scores in Patients With Lymphoma and Multiple Myeloma: A Moroccan Single-Center Retrospective Study
Authors: Oumayma Mnafe, Asmae Jamlaoui, Hicham Eddou
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 4, 2026, 10:01Ifeanyichukwu Ifechidere: Making Coagulation Simpler and More Practical
-
Sep 4, 2026, 09:49Omid Khalafi: When the ‘Rules of Three’ Break – What Is Really Happening?
-
Sep 4, 2026, 09:27Hilly Paige: What ESC 2026 Taught Us About LDL-C Management
-
Sep 4, 2026, 05:38Faizan Khan: Why Common Exposures Matter in VTE Risk
-
Sep 4, 2026, 04:56Marwa Mostafa: Microcytosis Is Not Always Iron Deficiency
-
Sep 4, 2026, 03:18Mukesh Kumar Maurya: Beyond ‘aPL Thrombosis’ – A Modern Approach to APS
-
Sep 4, 2026, 02:44Ahmed Kotb: Emergency Management of Critical Bleeding in ITP
-
Sep 4, 2026, 02:30Mario Jimenez: KDIGO 2026 – A More Proactive Approach to IV Iron in Hemodialysis
-
Sep 4, 2026, 02:18Edgardo Alania: Edoxaban in Intracranial Haemorrhage Survivors with AF